{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:47:28Z","timestamp":1775123248632,"version":"3.50.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Fulminant type 1 diabetes is a recently recognized diabetes subtype characterized by extremely rapid destruction of the pancreatic beta cells, leading to an absolute deficiency in insulin secretion. Fulminant type 1 diabetes is clinically characterized by the drastic onset of hyperglycemia and ketoacidosis within a few days, as well as near-normal glycated hemoglobin (HbA<jats:sub>1c<\/jats:sub>) levels despite remarkable hyperglycemia at initial presentation. A 41-year-old woman diagnosed with fulminant type 1 diabetes underwent <jats:sup>68<\/jats:sup>Ga-FAPI PET\/CT, which showed intense FAPI uptake throughout the pancreas, especially in the pancreatic tail. Contrast-enhanced abdominal CT failed to reveal any pancreatic abnormalities. This case indicated that <jats:sup>68<\/jats:sup>Ga-FAPI PET\/CT might be useful for evaluating patients with fulminant type 1 diabetes.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004684","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T18:00:09Z","timestamp":1683828009000},"page":"620-621","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["68Ga-FAPI PET\/CT Imaging of the Pancreas in a Patient With Fulminant Type 1 Diabetes"],"prefix":"10.1097","volume":"48","author":[{"given":"Seon-Young","family":"Park","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jahae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ook","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangbin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Jin","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ncpendmet0351","article-title":"Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners","volume":"3","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/jdi.13091","article-title":"Pathogenesis of fulminant type 1 diabetes: genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research","volume":"10","year":"2019","journal-title":"J Diabetes Investig"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/RLU.0000000000003489","article-title":"Fibroblast activation protein inhibitor PET\/CT: a promising molecular imaging tool","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"(68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/annrheumdis-2020-217408","article-title":"Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging","volume":"79","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/RLU.0000000000003703","article-title":"68Ga-FAPI PET\/CT imaging of graves ophthalmopathy in a patient with esophageal cancer","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","first-page":"212","article-title":"Imaging inflammation with positron emission tomography","volume":"9","year":"2021","journal-title":"Biomedicine"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"e67454","DOI":"10.1371\/journal.pone.0067454","article-title":"Regional differences in islet distribution in the human pancreas\u2014preferential beta-cell loss in the head region in patients with type 2 diabetes","volume":"8","year":"2013","journal-title":"PloS One"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:05:04Z","timestamp":1750532704000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004684","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,11]]}}}